PEAK PROCESSING LIMITED
ASX:PKPPharmaceuticals, Biotechnology & Life SciencesRunway under 2 quarters; share count grew 15% in 24 months; 4 cash raises in 24 months
PEAK PROCESSING LIMITED’s ordinary share count grew 15.2% between February 2026 and July 2026, to 1.33B shares. The company raised capital four times in that period for total disclosed proceeds of A$10.2M, most recently a Convertible Note Raising of A$2.4M in May 2026. Options and rights on issue could convert into 184M new shares, equal to 13.8% of the current share count, with 0% in the money and the nearest expiry in February 2027. At the March 2026 quarter the company reported A$-579K in available cash, equal to -0.2 quarters of cover. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in November 2026.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 24 July 2026 | 2A · quoted issue | PKP : ORDINARY FULLY PAID | 1.33B | Appendix 2A |
| 30 June 2026 | 3G · unquoted | PKP : ORDINARY FULLY PAID | 1.16B | Appendix 3G |
| 29 June 2026 | 2A · quoted issue | PKP : ORDINARY FULLY PAID | 1.16B | Appendix 2A |
| 29 June 2026 | 2A · quoted issue | PKP : ORDINARY FULLY PAID | 1.16B | Appendix 2A |
| 29 June 2026 | 2A · quoted issue | PKP : ORDINARY FULLY PAID | 1.32B | Appendix 2A |
Capital raises
4 cash raises in the last 24 months · 4 in the last 12 months
Pending proposed issues
Options & convertible securities
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.